Poor prognosis indicators of type-2 diabetic COVID-19 patients

Butantan affiliation
Publication type
Access rights
Open access
Terms of use
Appears in Collections:
Diabetes is associated with a worse prognosis and a high risk of morbidity and mortality in COVID-19 patients. We aimed to evaluate the main factors involved in the poor prognosis in diabetic patients. A total of 984 patients diagnosed with COVID-19 admitted to the hospital were included in this study. Patients were first divided into type-2 diabetic (DM+) and non-diabetic (DM–) groups. The participants were analyzed based on the National Early Warning Score (NEWS) and on the Quick-Sequential Organ Failure Assessment (qSOFA) to find the best prognostic risk score for our study. The DM+ and DM– groups were divided into non-severe and severe groups. Comparative and correlative analyses were used to identify the physiological parameters that could be employed for creating a potential risk indicator for DM+ COVID-19 patients. We found a poorer prognosis for the DM+ COVID-19 patients with a higher ICU admission rate, mechanical ventilation rate, vasopressor use, dialysis, and longer treatment times compared with the DM– group. DM+ COVID-19 patients had increased plasma glucose, lactate, age, urea, NEWS, and D-dimer levels, herein referred to as the GLAUND set, and worse prognosis and outcomes when compared with infected DM– patients. The NEWS score was a better indicator for assessing COVID-19 severity in diabetic patients than the q-SOFA score. In conclusion, diabetic COVID-19 patients should be assessed with the NEWS score and GLAUND set for determining their prognosis COVID-19 prognosis.
Gorjão R., Hirabara S.M., Masi L.N., Serdan T.D.A., Gritte R.B., Hatanaka E., et al. Poor prognosis indicators of type-2 diabetic COVID-19 patients. Braz. J. Med. Biol. Res. 2022 June;55:e11819. doi:10.1590/1414-431X2022e11819.
Link to cite this reference
Issue Date

Files in This Item:

download (1).pdf
Size: 556.58 kB
Format: Adobe PDF
Show full item record

This item is licensed under a Creative Commons License Creative Commons